ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

NCI Seeks To Fund More Cancer Centers, Provide 2% Inflationary Increase For Grants

February 5, 2010

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

DCT Bard Okays Concepts for BRMP Contract Programs

June 22, 1984

Edelson To Step Down As Yale Center Director.

January 11, 2008